<?xml version="1.0" encoding="UTF-8"?>
<p>Interestingly, a quantitative variation in ACE1 levels has been demonstrated to be modulated also by the 
 <italic>ABO</italic>-blood group locus (9q34.2). Moreover, selected 
 <italic>ABO</italic> polymorphisms (rs495828, gene promoter, and rs8176746, exon 7) influence ACE inhibitors treatment response [
 <xref rid="B90-ijms-21-03474" ref-type="bibr">90</xref>,
 <xref rid="B91-ijms-21-03474" ref-type="bibr">91</xref>,
 <xref rid="B92-ijms-21-03474" ref-type="bibr">92</xref>], and might contribute in reducing SARS-CoVsâ€™ transmission, in terms of number of infected individuals and epidemic rate reduction. This ascribed to O-blood group a lower risk of infection, hypothesizing that natural anti-A and anti-B antibodies can contribute in protecting against viral diseases at the population level [
 <xref rid="B93-ijms-21-03474" ref-type="bibr">93</xref>].
</p>
